Inventor · disambiguated record
Angela Brodie
Also filed as: BRODIE ANGELA · BRODIE ANGELA M · BRODIE ANGELA M H
14 granted patents·12 pending applications·312 citations·filing 1978–2016
94Inventor score
Top patents by PatentIndex Score
26 records- 0192US7875599B2C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens, in vitro biological activities, pharmacokinetics and antitumor activityUNIV MARYLAND·Filed 2006·Granted Jan 25, 2011·21 cites·17 claims
- 0291US9018198B2Prodrugs of C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activityUNIV MARYLAND·Filed 2014·Granted Apr 28, 2015·7 cites·20 claims
- 0391US6444683B217-azolyl steroids useful as androgen synthesis inhibitorsUNIV MARYLAND·Filed 2000·Granted Sep 3, 2002·30 cites·10 claims
- 0488US4235893AEster derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesisBRODIE ANGELA M·Filed 1978·Granted Nov 25, 1980·55 cites·6 claims
- 0587US9295679B2Prodrugs of C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activityUNIV MARYLAND·Filed 2015·Granted Mar 29, 2016·3 cites·12 claims
- 0685US8785423B2Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseasesNJAR VINCENT·Filed 2009·Granted Jul 22, 2014·7 cites·8 claims
- 0783US8110550B2HDAC inhibitors and hormone targeted drugs for the treatment of cancerBRODIE ANGELA·Filed 2008·Granted Feb 7, 2012·8 cites·16 claims
- 0882US6133280AAndrogen synthesis inhibitorsUNIV MARYLAND·Filed 1999·Granted Oct 17, 2000·52 cites·13 claims
- 0982US5994335A17-azolyl steroids useful as androgen synthesis inhibitorsUNIV MARYLAND·Filed 1997·Granted Nov 30, 1999·47 cites·59 claims
- 1075US2010137269A1Novel C-17-Heteroaryl Steroidal Cyp17 Inhibitors/Antiandrogens: Synehesis, In Vitro Biological Activities, Pharmacokinetics and Antitumor ActivityBRODIE ANGELA·Filed 2009·Application pending·0 cites
- 1172US7265143B2C-4 substituted retinoidsUNIV MARYLAND·Filed 2003·Granted Sep 4, 2007·10 cites·37 claims
- 1272US6200965B117-Azolyl steroids useful as androgren synthesis inhibitorsUNIV MARYLSND BALTIMORE·Filed 1999·Granted Mar 13, 2001·33 cites·7 claims
- 1371US2011118219A1Novel prodrugs of c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activityUNIV MARYLAND·Filed 2009·Application pending·0 cites
- 1468US10098896B2C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens, in vitro biological activities, pharmacokinetics and antitumor activityTHE UNIV OF MARYLAND BALTIMORE·Filed 2016·Granted Oct 16, 2018·0 cites·6 claims
- 1567US2014288036A1Novel c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens, in vitro biological activities, pharmacokinetics and antitumor activityUNIV MARYLAND·Filed 2013·Application pending·0 cites
- 1666US5994334AAndrogen synthesis inhibitorsUNIV MARYLAND·Filed 1997·Granted Nov 30, 1999·21 cites·23 claims
- 1765US2010048524A1Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor ActivityBRODIE ANGELA·Filed 2009·Application pending·0 cites
- 1865US2010048914A1Novel C-17-Heteroaryl Steroidal Cyp17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor ActivityBRODIE ANGELA·Filed 2009·Application pending·0 cites
- 1964US2010048912A1Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor ActivityBRODIE ANGELA·Filed 2009·Application pending·0 cites
- 2064US2010047338A1Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor ActivityBRODIE ANGELA·Filed 2009·Application pending·0 cites
- 2164US2010048913A1Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor ActivityBRODIE ANGELA·Filed 2009·Application pending·0 cites
- 2260US5264427A20-substituted pregnene derivatives and their use as androgen synthesis inhibitorsRES CORP TECHNOLOGIES INC·Filed 1992·Granted Nov 23, 1993·18 cites·5 claims
- 2359US2011105445A1Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancerUNIV MARYLAND·Filed 2009·Application pending·0 cites
- 2447US2012108522A1Hdac inhibitors and hormone targeted drugs for the treatment of cancerBRODIE ANGELA·Filed 2012·Application pending·0 cites
- 2546US2012122908A1Novel C-4 Substituted RetinoidsNJAR VINCENT C O·Filed 2007·Application pending·0 cites
- 2642US2015297615A1Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancerUNIV MARYLAND·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →